Transcript Intelligence: Pharming Group Q1 Earnings Guidance
StreetAccount Summary - Trading higher/lower: EU mid-morning
Pharming Group reports Q1 EPS ($0.01) vs FactSet $0.00 [3 est, ($0.00)-0.00] (€1.40, 0.00)
PharmAla Signs Supply and Data Agreement With Nautilus Sanctuary for Phase 2 MDMA Trial
Transcript Intelligence: Pharming Group at Needham Virtual Healthcare Conference
Pharming Group initiated buy at Canaccord Genuity ($16.98, 0.00)
Powered by FactSet Research Systems Inc.